PortalPublikationenPhase I/II study of the deacetylase inhibitor panobinostat a...

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

Standard

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial). / Bug, G; Burchert, A; Wagner, E-M; Kröger, N; Berg, T; Güller, S; Metzelder, S K; Wolf, A; Hünecke, S; Bader, P; Schetelig, J; Serve, H; Ottmann, O G.

in: LEUKEMIA, Jahrgang 31, Nr. 11, 11.2017, S. 2523-2525.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Bug, G, Burchert, A, Wagner, E-M, Kröger, N, Berg, T, Güller, S, Metzelder, SK, Wolf, A, Hünecke, S, Bader, P, Schetelig, J, Serve, H & Ottmann, OG 2017, 'Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)', LEUKEMIA, Jg. 31, Nr. 11, S. 2523-2525. https://doi.org/10.1038/leu.2017.242

APA

Bug, G., Burchert, A., Wagner, E-M., Kröger, N., Berg, T., Güller, S., Metzelder, S. K., Wolf, A., Hünecke, S., Bader, P., Schetelig, J., Serve, H., & Ottmann, O. G. (2017). Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial). LEUKEMIA, 31(11), 2523-2525. https://doi.org/10.1038/leu.2017.242

Vancouver

Bug G, Burchert A, Wagner E-M, Kröger N, Berg T, Güller S et al. Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial). LEUKEMIA. 2017 Nov;31(11):2523-2525. https://doi.org/10.1038/leu.2017.242

Bibtex

@article{8d5ce4caa4c246ef93f8c997abb4deb7,
title = "Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)",
keywords = "Journal Article",
author = "G Bug and A Burchert and E-M Wagner and N Kr{\"o}ger and T Berg and S G{\"u}ller and Metzelder, {S K} and A Wolf and S H{\"u}necke and P Bader and J Schetelig and H Serve and Ottmann, {O G}",
note = "Letter",
year = "2017",
month = nov,
doi = "10.1038/leu.2017.242",
language = "English",
volume = "31",
pages = "2523--2525",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "11",

}

RIS

TY - JOUR

T1 - Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

AU - Bug, G

AU - Burchert, A

AU - Wagner, E-M

AU - Kröger, N

AU - Berg, T

AU - Güller, S

AU - Metzelder, S K

AU - Wolf, A

AU - Hünecke, S

AU - Bader, P

AU - Schetelig, J

AU - Serve, H

AU - Ottmann, O G

N1 - Letter

PY - 2017/11

Y1 - 2017/11

KW - Journal Article

U2 - 10.1038/leu.2017.242

DO - 10.1038/leu.2017.242

M3 - Other (editorial matter etc.)

C2 - 28751769

VL - 31

SP - 2523

EP - 2525

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 11

ER -